My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 117

    1.

    A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease.

    Brophy DF, Martin RJ, Gehr TW, Carr ME Jr.

    Thromb J. 2005 Mar 29;3(1):3.PMID: 15796773 [PubMed - as supplied by publisher]Related articlesFree article

    3.

    Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time.

    Brophy DF, Martin EJ, Gehr TW, Carr ME Jr.

    Am J Kidney Dis. 2004 Aug;44(2):270-7.PMID: 15264185 [PubMed - indexed for MEDLINE]Related articles

    4.

    Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal disease.

    Brophy DF, Martin EJ, Gehr TW, Best AM, Paul K, Carr ME Jr.

    J Thromb Haemost. 2006 Feb;4(2):372-6.PMID: 16420568 [PubMed - indexed for MEDLINE]Related articles

    5.

    Development of platelet contractile force as a research and clinical measure of platelet function.

    Carr ME Jr.

    Cell Biochem Biophys. 2003;38(1):55-78. Review.PMID: 12663942 [PubMed - indexed for MEDLINE]Related articles

    6.

    Platelet contractile force (PCF) and clot elastic modulus (CEM) are elevated in diabetic patients with chest pain.

    Carr ME, Krishnaswami A, Martin EJ.

    Diabet Med. 2002 Oct;19(10):862-6.PMID: 12358876 [PubMed - indexed for MEDLINE]Related articles

    7.

    Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.

    Carr ME Jr, Martin EJ, Carr SL.

    Blood Coagul Fibrinolysis. 2002 Apr;13(3):193-7.PMID: 11943932 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.

    Brophy DF, Martin EJ, Nolte ME, Kuhn JG, Carr ME Jr.

    Haemophilia. 2007 Sep;13(5):533-41.PMID: 17880440 [PubMed - indexed for MEDLINE]Related articles

    9.

    Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force and clot elastic modulus.

    Krishnaswami A, Carr ME Jr, Jesse RL, Kontos MC, Minisi AJ, Ornato JP, Vetrovec GW, Martin EJ.

    Thromb Haemost. 2002 Nov;88(5):739-44.PMID: 12428087 [PubMed - indexed for MEDLINE]Related articles

    10.

    The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapies.

    Brophy DF, Carr ME Jr, Martin EJ, Venitz J, Gehr TW.

    J Clin Pharmacol. 2006 Aug;46(8):887-94.PMID: 16855073 [PubMed - indexed for MEDLINE]Related articles

    11.

    The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.

    Brophy DF, Martin EJ, Carr SL, Kirschbaum B, Carr ME Jr.

    Thromb Res. 2007;119(6):723-9. Epub 2006 Jun 21.PMID: 16793120 [PubMed - indexed for MEDLINE]Related articles

    12.

    Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies.

    Carr ME Jr, Carr SL, Tildon T, Fisher LM, Martin EJ.

    J Thromb Haemost. 2003 Feb;1(2):243-9.PMID: 12871496 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.

    Carr ME Jr, Angchaisuksiri P, Carr SL, Martin EJ.

    Cell Biochem Biophys. 2003;39(2):89-99.PMID: 14515016 [PubMed - indexed for MEDLINE]Related articles

    14.

    Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.

    Georgescu A, Popov D, Dragan E, Dragomir E, Badila E.

    Eur J Pharmacol. 2007 Sep 10;570(1-3):149-58. Epub 2007 Jun 5.PMID: 17612521 [PubMed - indexed for MEDLINE]Related articles

    15.

    Parametric clearance kidney scintigrams; diagnostic potential in diabetes.

    Frieske I, Surma MJ, Rogozińska-Zawiślak A, Szadkowska A, Gadzicki M, Bodalski J, Kuśmierek J.

    Nucl Med Rev Cent East Eur. 2007;10(1):16-20.PMID: 17694496 [PubMed - indexed for MEDLINE]Related articles

    16.

    Peak antifactor xa activity produced by dalteparin treatment in patients with renal impairment compared with controls.

    Shprecher AR, Cheng-Lai A, Madsen EM, Cohen HW, Sinnett MJ, Wong ST, Billett HH.

    Pharmacotherapy. 2005 Jun;25(6):817-22.PMID: 15927900 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Red cell system and selected red cell enzymes in men occupationally exposed to mercury vapours]

    Zabiński Z, Rutowski J, Moszczyński P, Dabrowski Z.

    Przegl Lek. 2006;63 Suppl 7:74-83. Polish. PMID: 17784549 [PubMed - indexed for MEDLINE]Related articles

    18.

    Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus.

    Miyazato J, Horio T, Takiuchi S, Kamide K, Sasaki O, Nakamura S, Nakahama H, Inenaga T, Takishita S, Kawano Y.

    Diabet Med. 2005 Jun;22(6):730-6.PMID: 15910624 [PubMed - indexed for MEDLINE]Related articles

    19.

    Platelet and clotting activities after cold stress in diabetic patients.

    Maiello M, Boeri D, Bonadonna R, Odetti P, Saccarello A, Adezati L.

    Thromb Res. 1988 Jun 15;50(6):885-94.PMID: 2970690 [PubMed - indexed for MEDLINE]Related articles

    20.

    Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome.

    Undas A, Wiek I, Stêpien E, Zmudka K, Tracz W.

    Diabetes Care. 2008 Aug;31(8):1590-5. Epub 2008 May 16.PMID: 18487475 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk